Philip McCarthy

Hematologic Oncology
2023 Buffalo Spree Top Doctors Badge

Dr. McCarthy is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2023

Cancers Treated:

Specializing In:

Blood Marrow Transplant Hematologic Oncology Acute and chronic leukemias Aplastic Anemia Hodgkin lymphoma (HL) Multiple myeloma Myelodysplastic syndromes Non-Hodgkin lymphoma (NHL) Testicular cancer

Research Interests:

Health effects of radiation exposure Modulation of chemotherapy toxicity Modulation of graft versus host disease Blood and marrow stem cell isolation Immune modulation after transplantation Cancer immunotherapy Preclinical models of bone marrow transplantation Models for patient outcomes after blood and marrow transplantation

About Philip McCarthy


My research interests are devoted to developing novel intensive and reduced intensity allogeneic and autologous hematopoietic stem cell transplant (HSCT) approaches for the treatment of hematologic disorders, leading to improved patient outcomes and decreased toxicity. I have over 20 years of experience treating HSCT patients and directing clinical and translational HSCT research studies. I have served as chair, or co-chair, of several clinical trials, including CALGB 100104, a phase III clinical trial evaluating lenalidomide maintenance after autologous HSCT for multiple myeloma (MM). This study demonstrated an improved progression-free and overall survival for MM patients receiving lenalidomide maintenance therapy after autologous HSCT. Our team has developed a systematic approach to the evaluation and treatment of HSCT patients with a specific focus on predicting and minimizing treatment-related mortality (TRM). We participate with a core group of basic science and clinical researchers who are committed to the investigation of the complications of autologous and allogeneic HSCT and to the developing novel approaches to improve outcomes.


Roswell Park Comprehensive Cancer Center

  • Professor of Oncology and Internal Medicine
  • Director Emeritus of the Transplant & Cellular Therapy Center, Department of Medicine
  • The Dr. Philip L. McCarthy Endowed Chair in Transplant & Cellular Therapy

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

  • Professor of Oncology and Internal Medicine


Education and Training:

  • MD - Tufts University School of Medicine, Boston, MA


  • Yale-New Haven Hospital, Yale University, New Haven, CT


  • Brigham and Women’s Hospital, Harvard University, Boston, MA

Board Certification:

  • Internal Medicine, American Board of Internal Medicine
  • Hematology, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Professional Memberships:

  • American Society of Hematology (ASH)
  • American Society for Blood and Marrow Transplantation (ASBMT)
  • International Society for Cellular Therapy (ISCT)
  • American Society of Clinical Oncology (ASCO)
  • American Association of Blood Banking
  • American Association for Cancer Research (AACR)

Honors & Awards:

  • 2015-2016 Castle Connolly America’s Top Doctors, Hematology
  • 2005-2013 Best Doctors in America

Clinical Trials

Featured on Cancer Talk